Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
National

GSK's Jemperli meets main goal in mid-stage rectal cancer trial

GSK ​said on Monday ​its cancer drug Jemperli met the primary goal ​of a mid-stage trial, with a clinically significant rate of patients showing no detectable signs of cancer for one year or ‌more after ⁠treatment ⁠for a specific type of locally advanced rectal cancer.

Here are some ​details:

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.